Sen. Bernie Sanders, I-Vt. sends letter to Catalyst Pharmaceuticals over decision to price drug previously available free to some patients at $375,000 per year.
Sen. Bernie Sanders, I-Vt. sends letter to Catalyst Pharmaceuticals over decision to price drug previously available free to some patients at $375,000 per year.
Sen. Bernie Sanders, I-Vt. sends letter to Catalyst Pharmaceuticals over decision to price drug previously available free to some patients at $375,000 per year.